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Intrinsic checkpoints for lineage progression
A new T-cell receptor oa-chain-like molecule has been
identified in precursor T cells. This protein may be part
of a receptor complex that induces T-cell maturation.
Development of the B and T lymphocytes that constitute
the body's main means of recognizing foreign antigens
proceeds via a discrete series of developmental stages. A
key feature of this process is that proper rearrangement
and expression of antigen-receptor genes are required for
developmental progression [1]. The mechanism by which
this process occurs in developing T cells has recently
become clearer, as the molecular nature of an antigen-
receptor-like complex expressed on precursor T cells has
been defined [2].
The T-cell antigen receptor is composed of two im-
munoglobulin-like antigen-recognizing subunits - ot
and P chains for most T cells (hereafter called TCROt and
TCR3 chains) - and a number of non-variable chains
- the and CD3 y, 8 and E chains - that are required
for cell-surface expression and signal transduction [3]
(Fig. 1). Like the genes encoding B-cell immunoglobulin
heavy p, and light K chains, the genes encoding the
TCRo and TCRP3 chains are organized in multiple seg-
ments - V, D andJ, for variable, diversity and joining -
that are assembled by recombination during T-cell devel-
opment. Distinct rearrangements occur in each lympho-
cyte, which consequently express an antigen receptor of
effectively unique specificity [4].
Failure to produce functional rearrangements of T-cell
receptor or immunoglobulin genes, either naturally
because of the inherently error-prone V(D)J recombina-
tion process or as a result of various mutations in geneti-
cally altered mice, blocks the developmental progression
of T or B cells, respectively [1,5]. For example, genetic
inactivation of the TCR3-chain locus [6,7] leads to T-
cell development arresting at the early CD4-CD8- 'dou-
ble-negative' stage, defined by lack of expression of either
CD4 or CD8 co-receptor chains. Restoration of TCR3-
chain expression with a rearranged transgene promotes
maturation to the next stage of T cell development -
the CD4+CD8+ 'double-positive' stage [6] (Fig. 2).
These observations indicate that expression of a TCR[
chain by a developing T cell initiates a sensing event that
acts as an intrinsic checkpoint for maturation. Expression
of immunoglobulin heavy chain serves an analogous
checkpoint function for B-cell development [8] (Fig. 2).
How does a precursor T cell sense productive TCR3-
gene rearrangement? Clues to a possible mechanism
come from the observation that productive rearrange-
ment of the TCR3 gene results in the expression of a
TCR[3 complex at the surface of precursor T cells [9].
Immunoprecipitation experiments show that the TCR3
chain in these cells covalently associates with a 33 kD gly-
coprotein, now called the pre-Tot chain [10]. The gene
encoding this protein has recently been cloned [2]. From
the gene's sequence, the pre-To chain is predicted to be
a type 1 transmembrane protein with a cytoplasmic tail
containing two potential protein kinase C phosphoryla-
tion sites. The extracellular domain contains a single
immunoglobulin-like domain with conserved cysteine
residues for intra-chain disulfide bonds and for dimeriza-
tion with TCRP. Like conventional TCRaot chains, pre-
To has charged residues within its putative transmernm-
brane region [2]. These charged residues in the TCRot
chain are required for proper assembly and cell-surface
transport of conventional T-cell receptor complexes [3].
Fig. 1. Structural components of the T-cell antigen receptor (TCR)
and B-cell antigen receptor (BCR) and of the related receptors ex-
pressed during T-cell or B-cell development (pre-TCR and pre-
BCR, respectively). By analogy with the pre-BCR structure, the
pre-TCR may contain an as yet unidentified component that con-
tains a variable-type immunoglobulin domain to pair with the va-
riable domain of the TCR[ chain. A -5 homodimer has not yet
been found associated with the pre-TCR [10]; however, a possible
weak association of the pre-TCR with is indicated in the figure,
because T-cell development is impaired in -deficient mice [5].
© Current Biology 1995, Vol 5 No 4 349
350 Current Biology 1995, Vol 5 No 4
Fig. 2. Developing T cells and Bcells progress through a series of discrete stages. Early T-cell precursors (double-negative thymocytes)
are characterized by lack of expression of CD4 and CD8. TCRP chain expression and Lck function are required for progression to the
next stage, CD4+CD8+ double-positive thymocytes, which initially express the pre-TCR. These cells stop rearranging TCRI loci and
start rearranging TCRa loci. Once a TCRa chain is made, the cells undergo positive and negative selection based on the specificity of
the T-cell receptors they express. Positive selection based on reactivity for major histocompatibility complex (MHC) molecules leads to
progression to the CD4+ or CD8+ single-positive stage, after which the T cells are fully mature and leave the thymus. B cells follow an
analogous developmental pathway, with the exception that positive selection based on antigen specificity may not be required.
Expression of the pre-BCR is required for progression from the pre-B1 to the pre-B2 stage. Functional light-chain gene expression is
required to complete development and allow exit of B cells from the bone marrow. Stages at which development is arrested in
specified genetically defective mice are shown (ras DN refers to expression of a gene encoding a dominant-negative form of Ras).
Thus, the structure of the newly described pre-To chain
supports the hypothesis that it combines with the TCRfi
chain to form an antigen-receptor-like complex, here-
after called the pre-TCR (Fig. 1). The pre-TCR com-
plex is postulated to induce developmental progression
to the CD4+CD8 + double-positive stage (Fig. 2). Sub-
sequent rearrangement and expression of a functional
TCRo-chain gene allows the formation of a convention-
al T-cell receptor oat heterodimer. The resulting precusor
T cell further develops to the mature T-cell state if the
ligand-binding specificity of its T-cell receptor is appro-
priate to allow positive, but not negative, selection (see
[11,12] for review).
One striking feature of the pre-TCR is its similarity to
antigen-receptor-like molecules expressed by developing
precursor B cells. During B-cell development, precursor
cells transit through a characteristic series of develop-
mental stages (Fig. 2). The gene for the immunoglobulin
p,. heavy chain rearranges first during B-cell development
[13,14]. Once a functional . heavy chain is produced, it
forms a complex (the pre-BCR) with two immuno-
globulin light-chain-like proteins, called 5 and VpreB1
[15,16]. Like pre-Tot, X5 has a domain that is homolo-
gous to immunoglobulin constant regions. In contrast to
pre-To, X5 does not have transmembrane or cytoplasmic
domains [17]. This difference is to be expected, however,
as the TCRo chain is a transmembrane protein, whereas
immunoglobulin light chains are localized outside of the
membrane (Fig. 1). A more important apparent differ-
ence between the T-cell and B-cell results is the presence
in the pre-BCR complex of the other non-covalently
associated polypeptide, VpreBl [18] - so far no analogous
component of the pre-TCR has been discovered.
The similarity of 5 to an immunoglobulin constant
domain and of VpreBl to an immunoglobulin variable
domain suggested that these two polypeptides bind to an
immunoglobulin heavy chain in a manner analogous to a
normal light chain, and act as surrogate light chains [17]
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(Fig. 1). Just as the pre-Tot-TCRP complex associates
with CD3 components, the VpreB-k5-Ix complex asso-
ciates with the accessory chains Ig-ox and Ig-P [19]. In
mature B cells, Ig-cx and Ig- 3 facilitate the transport of
immunoglobulin heavy and light chains to the cell surface,
and mediate signal transduction events initiating from the
B-cell antigen receptor [20]. In light of the structural
similarities between the pre-BCR and pre-TCR, it seems
likely that a VpreB-like molecule is associated with the
pre-Tot-TCR[3 complex.
The precise roles of the pre-TCR and the pre-BCR are
not known, although gene 'knock-out' experiments have
clearly shown that they are required for proper lymphoid
development. For example, B-cell and T-cell develop-
ment ceases at characteristic stages if the immunoglobu-
lin heavy-chain and TCRP genes, respectively, are not
successfully rearranged [21,22] (Fig. 2). Similarly, the X5
gene is critical in B-cell development, as knocking-out
this gene results in mice with greatly reduced production
of B cells [23]. One possibility is that the newly identi-
fied pre-Tot chain assists in receptor assembly and expres-
sion at the cell surface. Indeed, the X5 chain of the
pre-BCR is required for Ix-chain expression at the cell
surface [16]. A second possible function for the pre-
TCR and the pre-BCR is recognition of a stromal-cell
or epithelial-cell ligand in the supporting environment.
Lymphoid development occurs in a specific thymic
microenvironment in the case of T cells, and in the
bone marrow in the case of B cells, and is dependent
on cell-cell contact within these microenvironments.
The pre-TCR could mediate interactions with specific
components within the thymic microenvironment.
As expression of the pre-TCR or the pre-BCR is
required for lymphocyte developmental progression, it
has been hypothesized that these molecules initiate sig-
naling events that indicate their presence. The signal
transduction mechanisms used by the pre-TCR and pre-
BCR are therefore of considerable interest. Cross-linking
pre-BCRs results in a number of signaling events, includ-
ing protein-tyrosine phosphorylation and calcium eleva-
tion [24]. These experiments demonstrate a potential
signaling ability of the pre-BCR. Hints as to what intra-
cellular components mediate pre-TCR signaling have
come from the generation of mice in which the protein-
tyrosine kinase Lck is inactivated, either by expression of
a dominant-negative allele or by knocking-out the Ick
gene [25,26]. In either case, T-cell development is specif-
ically abrogated at the CD4-CD8- to CD4+CD8+ transi-
tion, the same point at which it is blocked in the absence
of TCR-chain production. Moreover, expression of an
activated allele of lck can drive thymocytes through this
transition, even in the absence of TCRP chain [27].
Thus, Lck function is critical to promote the transition
between these T-cell stages or to drive the expansion and
survival of emerging CD4+CD8+ cells. In contrast, Ras
function is not required at this stage, but is required later
for positive selection [28]. A model for T-cell development
Fig. 3. Distinct biological phenomena regulated by the antigen-
receptor and related complexes expressed by lymphocytes. Some
of the same protein-tyrosine kinases associated' with, and poten-
tially activating, the T-cell receptor (TCR) or B-cell receptor
(BCR) can also associate with the pre-TCR or pre-BCR.
Stimulation of the receptors of mature T and B cells, however,
induces functional activation of the cells, whereas expression of
precursor receptors induces differentiation events.
emerges in which TCR3 chains assemble with pre-Tat
chains and the non-polymorphic CD3 chains to form a
receptor complex in progenitor T cells. This receptor
complex functions as a signal-transducing unit, using Lck
to transduce signals into the cell that effect transition to
the CD4+CD8+ stage. In this regard, it is interesting that
the pre-Tot cytoplasmic domain contains a proline-rich
region that may bind the Src homology 3 (SH3) domain
of Lck [2,29].
Signal transduction by the T-cell receptor in mature T
cells requires Lck as well as another cytoplasmic tyrosine
kinase, ZAP-70 [30]. Interestingly, humans with defec-
tive ZAP-70 have been found among patients with T-cell
immunodeficiency [31]. In these patients, mature T cells
are largely unresponsive to stimulation via the T-cell re-
ceptor. However, these patients show only a partial defect
in T-cell development, perhaps because thymocytes
express moderate levels of the highly related tyrosine
kinase Syk, whereas mature T cells express much less Syk
[32]. Another immunodeficiency, X-linked agammaglo-
bulinemia, involves loss-of-function mutations of a third
type of intracellular tyrosine kinase, Btk. In this disease,
there is a strong block in B-cell development [33]. The
role of Btk in B-cell development is not well understood,
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but some evidence suggests that it plays a role in B-cell 
receptor and possibly pre-BCR signaling [34-361. 
The identification and characterization of the structural 
components of the pre-BCR and pre-TCR provides 
insight into the mechanisms regulating lymphocyte 
development. The structure of these precursor lympho- 
cyte receptors is analogous to those of the antigen recep- 
tors of mature B and T cells. However, the biological 
outcome of signaling through these different receptors is 
distinct (Fig. 3). The challenge for the future is to dissect 
the signal transduction events induced by these receptors 
and to determine the mechanisms that relay proper and 
distinct developmental information to the progenitor 
lymphocytes. The cloning of the gene encoding pre-Ta 
[2] will facilitate molecular analysis of the pre-TCR, and 
may provide a means to identi6 how T-cell precursors 
transit through checkpoints in their development. 
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